Background : Severe community-acquired pneumonia (CAP) can develop into respiratory failure that requires mechanical ventilation (MV), which is associated with a higher rate of mortality. It was recently reported that a hydrocortisone infusion in severe CAP patients was associated with a significant reduction in the length of the hospital stay and mortality. This study evaluated efficacy of a hydrocortisone infusion for patients with severe CAP requiring MV. Methods : From February 2005 to July 2005, 13 patients (M : F = 10 : 3, mean age: 68.6±14.1 years), who were diagnosed with severe CAP and required MV, were enrolled in this study. Hydrocortisone was administered as an intravenous 200mg loading bolus, which was followed by an infusion at a rate of 10mg/hour for 7 days. The control group was comprised of patients with severe CAP requiring MV but in whom corticosteroid was not used before study period. The clinical and physiologic parameters on or by day 8 and the outcome in the hydrocortisone infusion group were compared with those in the control group. Results : 1) There was no significant difference in age, gender ratio, SAPS II, SOFA score, temperature, leukocyte count, PaO2/FiO2 (P/F) ratio, the number of patients with P/F ratio < 200, chest radiograph score, lung injury score and catecholamine-dependent septic shock between the hydrocortisone infusion group and control group at day 1. 2) At day 8, the proportion of patients with an improvement in the P/F ratio ≥ 100 and the chest radiograph score was significantly higher in the hydrocortisone infusion group than in the control group (61.5% vs. 15.4%, 76.9% vs. 23.1%, p< 0.05). However, there was no significant difference in the other clinical and physiologic parameters. 3). There was no significant difference in the duration of the MV, ICU stay, hospital stay and 10th and 30th day mortality between the two groups. Conclusion : Hydrocortisone infusion for patients with severe CAP requiring invasive mechanical ventilation may be effective in improving the level of oxygenation and the chest radiograph score. (Tuberc Respir Dis 2006; 60: 419-425) HC Kim et al. : Hydrocortisone infusion in severe community-acquired pneumonia 420 인자이다 5 . 전신 염증매개체의 증가는 패혈증, 다발성 장기 부전과 관련이 있고 사망률을 높이는 인자이므 로 전신 염증매개체를 감소시키는 약제를 투여함으 로써 사망률의 감소와 패혈증이나 다발성 장기 부전 의 발생을 예방할 수 있을 것으로 추측할 수 있다. 스테로이드는 강력한 항염증 효과를 나타내지만 과거 연구를 보면 패혈증이나 초기 급성호흡곤란증 후군 등에서 고용량의 전신적 투여로는 임상적 효과 를 입증하지 못하였다 6,7 . 그러나 최근에는 상대적 부 신기능 저하가 있는 패혈성 쇽 환자에서 장기간의 저 용량 하이드로코르티손 투여로 사망률을 감소시킬 수 있는 것으로 보고되었고 8 중증의 폐포자충(pneumocystitis carinni) 폐렴 9
Data are presented as the mean value ± SD or number of patients with percentage.
Definition of abbreviations: MV = Mechanical ventilation, P/F = PaO2/FiO2; SOFA= Sequential organ failure assessment, MODS = multiple organ dysfunction syndrome, ARDS = acute respiratory distress syndrome 참 고 문 헌
